Login / Signup

Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey.

Marlene StollLara HubenschmidCora KochKlaus LiebBoris Egloff
Published in: BMJ open (2022)
While confirmatory analyses did not provide significant results, descriptive analyses showed that participants who voluntarily disclose payments mainly do not experience any reactions towards their disclosures but report fears about losing their reputation due to disclosures.
Keyphrases
  • cross sectional
  • primary care
  • adverse drug